Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	85.68	-244.52	-1707.69
Graham Fair Price	21.48	0.14	0.12
PEG	13.40	2.77	-2.44
Price/Book	7.18	29.98	27.98
Price/Cash Flow	-14232.08	-16228.43	-113.23
Prices/Earnings	48.82	-93.74	-183.16
Price/Sales	-71.76	16.87	59.72
Price/FCF	-14232.08	-16228.43	-113.23
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	-45.22	0.08	0.15
Operating Margin	7.20	-0.07	-0.08
ROA	-32.79	-0.01	< 0.005
ROE	-0.04	-0.08	-109.43
ROIC	-0.03	-0.09	-207.36
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	0.00	7.00	inf
Dividends QOQ	0.92	0.02	-97.72
EBIT QOQ	-1.30	0.17	-86.90
EPS QOQ	-0.75	0.34	-54.87
FCF QOQ	-2.21	0.98	-55.71
Revenue QOQ	-0.46	3.39	644.47
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	7.07	3.11	-55.98
Days Sales Outstanding (DSO)	380.08	5.95	-98.43
Inventory Turnover	12.74	28.94	127.19
Debt/Capitalization	0.16	0.19	15.49
Quick Ratio	0.86	0.91	5.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	0.13	0.19	45.78
Cash	0.02	< 0.005	-74.81
Capex	< 0.005	< 0.005	8298.20
Free Cash Flow	-0.03	< 0.005	99.37
Revenue	0.06	0.19	218.55
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	0.93	0.92	-1.43
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-2.73	-1.53	43.89
Naive Interpretation	Member

06 - Financial Health · Bad

Rating